Unable to load your delegates due to an error This article is also available for rental through DeepDyve. This site needs JavaScript to work properly.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia.1–3 It is a progressive disease and is strongly associated with adverse clinical outcomes, including heart failure and stroke, resulting in considerable morbidity and mortality.4–6 Despite efforts at both rhythm and rate control, patients with AF and atrial flutter (AFL) are at a markedly increased risk of cardiovascular hospitalizations and cardiovascular death, particularly in older age groups. Search for other works by this author on: You do not currently have access to this article. Two retrospective studies were included for this comparison, 38, 39 and Figure 7 outlines the results of the meta-analysis of this study. Silverchair Information Systems Published on behalf of the European Society of Cardiology.
School of Nursing and Midwifery, Royal College of Surgeons in Ireland (RCSI), University of Medicine and Health SciencesFakeeh College of Health Sciences, Abdul Wahab Naib Al HaramFaculty of Medicine, Nursing and Health Sciences, Monash UniversityDepartment of Public Health, Faculty of Medicine and Health Sciences Dronedarone causes coronary vasodilatation that is refractory to the inhibition of the nitric oxide synthase pathway while amiodarone has coronary vasodilatation highly dependent on this pathway. Falls Bisoprolol die Herzfrequenz nicht ausreichend senken sollte, könnte eventuell zusätzlich Digitoxin in niedriger Dosierung eingenommen werden (z.
2019 Apr 30;11(6):2161. doi: 10.4022/jafib.2161. 2011 Jan-Feb;27(1):47-59. doi: 10.1016/j.cjca.2010.11.001.Europace. eCollection 2020.Curr Anesthesiol Rep. 2019 Jun;9(2):174-193. doi: 10.1007/s40140-019-00321-4. Als Benzofuranderivat ähnelt Dronedaron in der chemischen Struktur und der Wirkung dem Amiodaron.
As displayed, in the flecainide group, 58% (n = 28/48) had AF recurrence, conversely, in the dronedarone group, 65% (n = 35/54) had AF recurrence. doi: 10.1016/j.clinthera.2018.01.015. 2010 Oct;28(8):903-10. doi: 10.1016/j.ajem.2009.05.005. Do not use dronedarone if you have a type of atrial fibrillation (Afib) called permanent Afib. Beta-blocker therapy after myocardial infarction guided by left ventricular ejection fraction: is 50 the new 40? Off-label use of reduced dose direct oral factor Xa-inhibitors in subjects with atrial fibrillation: a review of clinical evidence Epub 2018 Feb 28.Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.Am J Cardiol. Silverchair Information Systems Oxford University Press is a department of the University of Oxford.
[4] Dronedaron ist eine Weiterentwicklung des Amiodarons und wurde entwickelt, um diese Nebenwirkungen zu reduzieren. 0,07 mg täglich). Search for other works by this author on: Artikel schreiben.
2018 Dec;48(12):1033-1080. doi: 10.4070/kcj.2018.0339. However, in light of the deficiency of volume and quality of available evidence, the writer acknowledges the requirement for future research.Most users should sign in with their email address. © The Author(s) 2020. Hannah Wilson, Declan Patton, Zena Moore, Tom O’Connor, Linda Nugent, Comparison of dronedarone vs. flecainide in the maintenance of sinus rhythm, following electrocardioversion in adults with persistent atrial fibrillation: a systematic review and meta-analysis, To compare flecainide and dronedarone for sinus rhythm (SR) maintenance following electrocardioversion of persistent atrial fibrillation (AF), in patients with minimal or no structural heart disease.A systematic search of publications using EMBASE, CENTRAL, CINAHL, and MEDLINE (1989–2019), identified a total of 595 articles.
Die Herzfrequenz sollte zwischen 80 und 110 Schlägen pro Minute liegen. Comparison 5: flecainide vs. dronedarone 2 studies; 102 participants. GBP £29.00
Please check your email address / username and password and try again. Methods and results: Electronic databases were systematically searched to identify randomized controlled trials (RCTs) examining amiodarone, dronedarone, flecainide, propafenone, sotalol, or placebo for the treatment of AF. Nine articles met the inclusion criteria [five randomized controlled trials (RCTs) and four cohort studies], encompassing 1349 persistent AF candidates. Dronedarone is a non-iodinated benzofuran developed specifically for the treatment of atrial fibrillation (AF), designed to retain the efficacy of amiodarone, but with an improved safety profile.
2019 Sep 4;9(9):CD005049. Don't already have an Oxford Academic account? Name must be less than 100 characters All rights reserved. Epub 2010 Mar 25.Wu C, Tcherny-Lessenot S, Dai W, Wang Y, Kechemir H, Gandhi S, Lin S, Juhaeri J.Clin Ther. COVID-19 is an emerging, rapidly evolving situation. To purchase short term access, please sign in to your Oxford Academic account above. Search for other works by this author on: If you originally registered with a username please use that to sign in. Atrial fibrillation is the most frequent arrhythmic c…
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia.1–3 It is a progressive disease and is strongly associated with adverse clinical outcomes, including heart failure and stroke, resulting in considerable morbidity and mortality.4–6 Despite efforts at both rhythm and rate control, patients with AF and atrial flutter (AFL) are at a markedly increased risk of cardiovascular hospitalizations and cardiovascular death, particularly in older age groups. Search for other works by this author on: You do not currently have access to this article. Two retrospective studies were included for this comparison, 38, 39 and Figure 7 outlines the results of the meta-analysis of this study. Silverchair Information Systems Published on behalf of the European Society of Cardiology.
School of Nursing and Midwifery, Royal College of Surgeons in Ireland (RCSI), University of Medicine and Health SciencesFakeeh College of Health Sciences, Abdul Wahab Naib Al HaramFaculty of Medicine, Nursing and Health Sciences, Monash UniversityDepartment of Public Health, Faculty of Medicine and Health Sciences Dronedarone causes coronary vasodilatation that is refractory to the inhibition of the nitric oxide synthase pathway while amiodarone has coronary vasodilatation highly dependent on this pathway. Falls Bisoprolol die Herzfrequenz nicht ausreichend senken sollte, könnte eventuell zusätzlich Digitoxin in niedriger Dosierung eingenommen werden (z.
2019 Apr 30;11(6):2161. doi: 10.4022/jafib.2161. 2011 Jan-Feb;27(1):47-59. doi: 10.1016/j.cjca.2010.11.001.Europace. eCollection 2020.Curr Anesthesiol Rep. 2019 Jun;9(2):174-193. doi: 10.1007/s40140-019-00321-4. Als Benzofuranderivat ähnelt Dronedaron in der chemischen Struktur und der Wirkung dem Amiodaron.
As displayed, in the flecainide group, 58% (n = 28/48) had AF recurrence, conversely, in the dronedarone group, 65% (n = 35/54) had AF recurrence. doi: 10.1016/j.clinthera.2018.01.015. 2010 Oct;28(8):903-10. doi: 10.1016/j.ajem.2009.05.005. Do not use dronedarone if you have a type of atrial fibrillation (Afib) called permanent Afib. Beta-blocker therapy after myocardial infarction guided by left ventricular ejection fraction: is 50 the new 40? Off-label use of reduced dose direct oral factor Xa-inhibitors in subjects with atrial fibrillation: a review of clinical evidence Epub 2018 Feb 28.Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.Am J Cardiol. Silverchair Information Systems Oxford University Press is a department of the University of Oxford.
[4] Dronedaron ist eine Weiterentwicklung des Amiodarons und wurde entwickelt, um diese Nebenwirkungen zu reduzieren. 0,07 mg täglich). Search for other works by this author on: Artikel schreiben.
2018 Dec;48(12):1033-1080. doi: 10.4070/kcj.2018.0339. However, in light of the deficiency of volume and quality of available evidence, the writer acknowledges the requirement for future research.Most users should sign in with their email address. © The Author(s) 2020. Hannah Wilson, Declan Patton, Zena Moore, Tom O’Connor, Linda Nugent, Comparison of dronedarone vs. flecainide in the maintenance of sinus rhythm, following electrocardioversion in adults with persistent atrial fibrillation: a systematic review and meta-analysis, To compare flecainide and dronedarone for sinus rhythm (SR) maintenance following electrocardioversion of persistent atrial fibrillation (AF), in patients with minimal or no structural heart disease.A systematic search of publications using EMBASE, CENTRAL, CINAHL, and MEDLINE (1989–2019), identified a total of 595 articles.
Die Herzfrequenz sollte zwischen 80 und 110 Schlägen pro Minute liegen. Comparison 5: flecainide vs. dronedarone 2 studies; 102 participants. GBP £29.00
Please check your email address / username and password and try again. Methods and results: Electronic databases were systematically searched to identify randomized controlled trials (RCTs) examining amiodarone, dronedarone, flecainide, propafenone, sotalol, or placebo for the treatment of AF. Nine articles met the inclusion criteria [five randomized controlled trials (RCTs) and four cohort studies], encompassing 1349 persistent AF candidates. Dronedarone is a non-iodinated benzofuran developed specifically for the treatment of atrial fibrillation (AF), designed to retain the efficacy of amiodarone, but with an improved safety profile.
2019 Sep 4;9(9):CD005049. Don't already have an Oxford Academic account? Name must be less than 100 characters All rights reserved. Epub 2010 Mar 25.Wu C, Tcherny-Lessenot S, Dai W, Wang Y, Kechemir H, Gandhi S, Lin S, Juhaeri J.Clin Ther. COVID-19 is an emerging, rapidly evolving situation. To purchase short term access, please sign in to your Oxford Academic account above. Search for other works by this author on: If you originally registered with a username please use that to sign in. Atrial fibrillation is the most frequent arrhythmic c…